Literature DB >> 22969045

Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.

Steffen Lindert1, J Andrew McCammon.   

Abstract

Enoyl-acyl carrier protein reductase (ENR) is a crucial enzyme in the type II fatty acid synthesis pathway of many pathogens such as Plasmodium falciparum, the etiological agent of the most severe form of malaria. Because of its essential function of fatty acid double bond reduction and the absence of a human homologue, PfENR is an interesting drug target. Although extensive knowledge of the protein structure has been gathered over the last decade, comparatively little remains known about the dynamics of this crucial enzyme. Here, we perform extensive molecular dynamics simulations of tetrameric PfENR in different states of cofactor and ligand binding, and with a variety of different ligands bound. A pocket-volume analysis is also performed, and virtual screening is used to identify potential druggable hotspots. The implications of the results for future drug-discovery projects are discussed.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22969045      PMCID: PMC3527710          DOI: 10.1002/pro.2155

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  35 in total

1.  Computational drug design accommodating receptor flexibility: the relaxed complex scheme.

Authors:  Jung-Hsin Lin; Alexander L Perryman; Julie R Schames; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2002-05-22       Impact factor: 15.419

2.  The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme.

Authors:  Jung-Hsin Lin; Alexander L Perryman; Julie R Schames; J Andrew McCammon
Journal:  Biopolymers       Date:  2003-01       Impact factor: 2.505

3.  Estimates of the ab initio limit for pi-pi interactions: the benzene dimer.

Authors:  Mutasem Omar Sinnokrot; Edward F Valeev; C David Sherrill
Journal:  J Am Chem Soc       Date:  2002-09-11       Impact factor: 15.419

4.  X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.

Authors:  Koustav Maity; Saligram Prabhakar Bhargav; Banumathi Sankaran; Namita Surolia; Avadhesha Surolia; Kaza Suguna
Journal:  IUBMB Life       Date:  2010-06       Impact factor: 3.885

5.  Molecular basis for triclosan activity involves a flipping loop in the active site.

Authors:  X Qiu; C A Janson; R I Court; M G Smyth; D J Payne; S S Abdel-Meguid
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Structural basis of triclosan resistance.

Authors:  N Jiten Singh; Dongkyu Shin; Han Myoung Lee; Hyun Tae Kim; Ho-Jin Chang; Joong Myung Cho; Kwang S Kim; Seonggu Ro
Journal:  J Struct Biol       Date:  2010-11-19       Impact factor: 2.867

Review 7.  Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).

Authors:  Xiaoyun Lu; Kun Huang; Qidong You
Journal:  Expert Opin Ther Pat       Date:  2011-06-09       Impact factor: 6.674

8.  Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.

Authors:  M Kapoor; M J Dar; A Surolia; N Surolia
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

9.  Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.

Authors:  Remo Perozzo; Mack Kuo; Amar bir Singh Sidhu; Jacob T Valiyaveettil; Robert Bittman; William R Jacobs; David A Fidock; James C Sacchettini
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

10.  Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target.

Authors:  William Sinko; César de Oliveira; Sarah Williams; Adam Van Wynsberghe; Jacob D Durrant; Rong Cao; Eric Oldfield; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-03-29       Impact factor: 2.817

View more
  4 in total

1.  Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.

Authors:  Lorillee C Tallorin; Jacob D Durrant; Quynh G Nguyen; J Andrew McCammon; Michael D Burkart
Journal:  Bioorg Med Chem       Date:  2014-09-15       Impact factor: 3.641

2.  In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.

Authors:  Steffen Lindert; Lorillee Tallorin; Quynh G Nguyen; Michael D Burkart; J Andrew McCammon
Journal:  J Comput Aided Mol Des       Date:  2014-10-25       Impact factor: 3.686

3.  Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.

Authors:  Benjamin Merget; Christoph A Sotriffer
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

4.  POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics.

Authors:  Jacob D Durrant; Lane Votapka; Jesper Sørensen; Rommie E Amaro
Journal:  J Chem Theory Comput       Date:  2014-09-29       Impact factor: 6.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.